Clinical Trial Update: Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK) [Phase 1]

View source ↗

Summary

Phase I clinical trial exploring preconditioning radiation therapy with IL-15–transduced TGFBR2 KO CAR.TROP2-engineered cord blood–derived NK cells for advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• IL-15 transduced TGFBR2 KO CAR.TROP2-engineered cord blood-derived NK cells

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head and Neck Cancer | Phase 1 | Status: RECRUITING